MedTrace Logo

Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure

NCT06038682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-03-01

No results posted yet for this study

Summary

A monocentric observational study evaluates the accuracy of anticoagulation monitoring in critically ill patients on ECLS (extracorporeal life support) using new markers of the effect of direct thrombin inhibitors and also the accuracy of anticoagulation monitoring in patients on unfractionated heparin using anti-Xa. A more accurate setting of anticoagulation may lead to a reduction in the number of serious bleeding and thrombotic complications in these patients.

Conditions

Interventions

DRUG

Argatroban Injection

Argatroban will be administered to the study subjects in this group in order to achieve anticoagulation.

DRUG

Heparin

Heparin will be administered to the study subjects in this group in order to achieve anticoagulation.

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Filip Burša, MD, Ph.D. · University Hospital Ostrava

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2023-07-31
Completion
2023-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06038682 on ClinicalTrials.gov